Searched query = "Wilson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||ChiCTR1900023410||2019-06-01||2019-05-26||The application of quantitative susceptibility mapping and blood and urine cell culture in Wilson's disease||The application of quantitative susceptibility mapping and blood and urine cell culture in Wilson's disease||Wilson’s disease||Gold Standard:The main clinical diagnostic criteria: 1) liver disease history, liver disease symptoms or extravertebral system symptoms; 2) serum ceruloplasmin was significantly decreased and/or liver copper increased; 3) corneal Kayser-Fleischer ring; 4) positive family history.;Index test:Quantitative susceptibility mapping;||Shanghai Tongren Hospital||NULL||Recruiting||Both||Target condition:40;Difficult condition:20||China|
|2||ChiCTR-DDD-17010552||2017-01-25||2017-02-04||Genetic diagnosis of Wilson's disease||Genetic diagnosis of Wilson's disease||Wilson Disease||Gold Standard:Clinical symptoms; Family history of genetic; Plasma ceruloplasmin levels;Urine copper levels of 24 hours; The nervous system of assessment and head imaging examination;Index test:Determination of gene sequence of the gene of ATP7B;||Anhui Provincial Hospital||NULL||Recruiting||Both||Target condition:20;Difficult condition:0||China|